CALISTOGA PHARMACEUTICALS
Calistoga Pharmaceuticals, Inc. is the leader in developing innovative oral medicines targeting selected isoforms of the PI3 kinase pathway to improve the health of patients with cancer and inflammatory diseases. The PI3K pathway is a critical cellular pathway involved in cell survival and immune cell activation. Calistoga Pharmaceuticals' small-molecule therapeutic candidates inhibit specific isoforms of the PI3K pathway, providing a targeted treatment approach designed to maximize clinical... outcome and limit unwanted side effects. Calistoga Pharmaceuticals' lead product, CAL-101, an oral delta-isoform selective PI3K inhibitor, has demonstrated promising clinical responses in patients with B-cell malignancies and is currently being evaluated in multiple clinical trials. In addition to CAL-101, Calistoga Pharmaceuticals' product development pipeline includes other selective PI3K inhibitors in early preclinical development or ready for initial clinical trials in patients with cancer or inflammatory diseases.
CALISTOGA PHARMACEUTICALS
Industry:
Alternative Medicine Biotechnology Medical
Founded:
2006-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.calistogapharma.com
Total Employee:
1+
Status:
Active
Contact:
07804443213
Total Funding:
97.2 M USD
Technology used in webpage:
SPF Mobile Non Scaleable Content Amazon Amazon Virginia Region NameBright Citrix NetScaler StatCounter
Similar Organizations
Epicyte Pharmaceuticals
Epicyte Pharmaceutical is focused on development therapeutic monoclonal antibodies for cancer, infectious and inflammatory diseases.
KinDex Pharmaceuticals
KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders.
Current Employees Featured
Founder
Investors List
Latterell Venture Partners
Latterell Venture Partners investment in Series C - Calistoga Pharmaceuticals
Amgen Ventures
Amgen Ventures investment in Series C - Calistoga Pharmaceuticals
Alta Partners
Alta Partners investment in Series C - Calistoga Pharmaceuticals
Quogue Capital
Quogue Capital investment in Series C - Calistoga Pharmaceuticals
Three Arch Partners
Three Arch Partners investment in Series C - Calistoga Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series C - Calistoga Pharmaceuticals
Alta Partners
Alta Partners investment in Series B - Calistoga Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - Calistoga Pharmaceuticals
Amgen Ventures
Amgen Ventures investment in Series B - Calistoga Pharmaceuticals
Three Arch Partners
Three Arch Partners investment in Series B - Calistoga Pharmaceuticals
Official Site Inspections
http://www.calistogapharma.com
- Host name: 104.21.2.125
- IP address: 104.21.2.125
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Calistoga Pharmaceuticals"
Calistoga Pharmaceuticals - Crunchbase Company …
Calistoga Pharmaceuticals, Inc. is the leader in developing innovative oral medicines targeting selected isoforms of the PI3 kinase pathway to improve …See details»
Calistoga Pharmaceuticals Management Team | Org Chart
Calistoga Pharmaceuticals employs 12 employees. The Calistoga Pharmaceuticals management team includes Mike Gallatin (President), Neill Giese (Chief Scientific Officer), and Daryl Winter …See details»
Calistoga Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
May 7, 2025 www.calistogapharma.com. Subsidiary Company | 2006 | Washington, United States | < 10 | www.calistogapharma.com. Last update 08 May 2025. Overview. Pipeline. …See details»
Calistoga Pharmaceuticals - Products, Competitors, Financials ...
Calistoga Pharmaceuticals is a biopharmaceutical company developing multiple compounds selectively targeting the PI3K pathway, a pathway known to be involved in certain cancers and …See details»
Team Site Traffic
When you join make sure you send a copy of your receipt to . Alright, now let’s talk details. Gavin’s training in the system shows you exactly how to build a thriving network marketing …See details»
Calistoga Pharmaceuticals - Ownership and Business Overview
Www.calistogapharma.com. Profile Investors (2) Analytics ... Calistoga is a privately held organization headquartered in Seattle. Company Summary. SECTOR. Life Science. …See details»
Calistoga Pharmaceuticals - Overview, Competitors, And ... - Ampliz
Calistoga Pharmaceuticals`s Overview, Revenue, Employee Size, Location For Free. Find Key Decision Makers Of Calistoga Pharmaceuticals Email, Phone, LinkedIn Profile.See details»
Calistoga Pharmaceuticals - LinkedIn
Calistoga Pharmaceuticals, Inc. is the leader in developing innovative oral medicines targeting selected isoforms of the PI3 kinase pathway to improve the health of patients with cancer and ...See details»
Calistoga Pharmaceuticals - PitchBook
Calistoga Pharmaceuticals General Information Description. Developer of medicines targeting selective isoforms of the PI3 kinase pathway to improve the health of patients with cancer, …See details»
Orphanet: CALISTOGA PHARMACEUTICALS, INC.
Dear Orphanet User, Your opinion is essential in improving the services offered by Orphanet. Your contribution to this survey is also indispensable for our funding agencies. Please could …See details»
Company Information - RocketReach
Calistoga Pharmaceuticals, Inc. is the leader in developing innovative oral medicines targeting selected isoforms of the PI3 kinase pathway to improve the health of patients with cancer and …See details»
Gilead Sciences to Acquire Calistoga Pharmaceuticals for $375 …
Feb 22, 2011 For more information, visit the company’s website at: www.calistogapharma.com. About Gilead Sciences. Gilead Sciences is a biopharmaceutical company that discovers, …See details»
Calistoga Pharmaceuticals - Company Info, Employees
View Calistoga pharmaceuticals calistogapharma.com location in 2101 4th ave, seattle, washington, 98121, united states, revenue, industry and description. Find related and similar …See details»
Calistoga Pharmaceuticals, Inc.: Drug pipelines, Patents, Clinical ...
Jul 16, 2023 Explore Calistoga Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 11 news, and 1 literature, Drug:Idelalisib, CAL-263.See details»
Calistoga Pharmaceuticals Overview | SignalHire Company Profile
Calistoga Pharmaceuticals, Inc. is the leader in developing innovative oral medicines targeting selected isoforms of the PI3 kinase pathway to improve the health of patients with cancer and …See details»
Calistoga Pharmaceuticals - Tech Company Profile - Gaebler.com …
Www.calistogapharma.com. Email Address [email protected] Company Background Information. Overview. Calistoga Pharmaceuticals, is developing a drug candidate acquired from Icos that …See details»
Calistoga Pharmaceuticals Raises $40 Million in Series C Financing
Jun 30, 2010 For more information, visit the Company’s website at: www.calistogapharma.com. CONTACT: Rathbun Communications, Inc. Julie Rathbun, 206-769-9219 [email protected]See details»
Calistoga Pharmaceuticals Appoints Carol G. Gallagher, Pharm. D., …
Oct 8, 2008 Calistoga Pharmaceuticals Appoints Carol G. Gallagher, Pharm. D., Chief Executive Officer SEATTLE--(BUSINESS WIRE)--October 8, 2008--Pharmaceuticals, Inc., a company …See details»
Gilead Sciences, Inc. to Acquire Calistoga Pharmaceuticals for $375 ...
Feb 22, 2011 FOSTER CITY, Calif. & SEATTLE--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) and Calistoga Pharmaceuticals, Inc., a privately-held biotechnology company …See details»
Ineffectiveness of Water Mist Spray to the upper body of healthy …
1 day ago The International Labour Organization estimated that 2.2% of total working hours and 80 million full-time jobs will be lost by 2030 even if the stringent control of CO 2 emissions in …See details»